September 30th 2024
The event will focus on innovating with cutting-edge technology, featuring the likes of pharmaceutical technology companies revolutionizing the industry.
Plavix biomarker test can improve patient outcomes
September 15th 2010In a novel collaboration with PBM giant CVS Caremark and its specialty pharmacy Generation Health, PGXL Laboratories will use its expertise in anticoagulants to improve the quality of patient care through pharmacogenetic testing, physician education, and drug-specific software programs.
State deals setback in drive to end pharmacy ownership restrictions in North Dakota
August 17th 2010The North Dakota secretary of state rejected thousands of signatures from a petition that would have put a measure on the November ballot to end the state?s restrictions on pharmacy ownership, the Associated Press reported.
FDA approves longer Valcyte therapy for CMV disease in adult kidney-transplant patients
August 17th 2010FDA approved increasing the length of therapy with Valcyte (valganciclovir hydrochloride) in adult kidney-transplant patients at high risk for cytomegalovirus (CMV) disease, according to an Aug. 10 statement made by Genentech Inc.
Hospital-acquired MRSA infections decline between 2005 and 2008
August 17th 2010Infections with the deadly methicillin-resistant Staphylococcus aureus (MRSA) bacteria contracted in hospitals and other healthcare settings have declined 28% over a 4-year period, according to a new Centers for Disease Control and Prevention (CDC) study of about 15 million people.
Novartis Vaccines begins shipment of seasonal influenza vaccine
August 17th 2010Novartis Vaccines has started shipping the FDA-approved seasonal influenza vaccine Fluvirin to U.S. customers ahead of the 2010&endash;2011 season, allowing healthcare practitioners to initiate protection of their patients well in advance.
FDA issues warning on stolen Advair Diskus inhalers
August 17th 2010Certain lots of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhalers that were stolen from a GlaxoSmithKline (GSK) distribution warehouse near Richmond, Va., in August 2009 have recently been found in some pharmacies, according to FDA.
FDA approves 3-in-1 combination drug for high blood pressure
August 17th 2010FDA has approved Tribenzor (olmesartan medoxomil, amlodipine, hydrochlorothiazide), a new three-in-one combination product taken once daily for the treatment of hypertension in patients who are not adequately controlled on any 2 of the following antihypertensive drug classes: angiotensin receptor blockers, calcium channel blockers, and diuretics, according to Daiichi Sankyo Inc.
Newer AEDs linked to self-harm, suicidal behavior
August 17th 2010Patients taking newer antiepileptic drugs (AEDs) that are associated with a high risk of depression may have an elevated risk of self-harm or suicidal behavior, but other groups of AEDs do not appear to carry the same risk, according to research published in the July 27 issue of Neurology and reported in HealthDay News.
OAD agents effective in reducing hemoglobin levels up to 1.5%
August 17th 2010Oral antidiabetic (OAD) agents generally result in a maximum 1.5% drop in hemoglobin (Hb) A1C levels, with sulfonylureas and thiazolidinediones having a slightly more beneficial effect than other classes of oral agents, according to research published in the August issue of Diabetes Care and reported by HealthDay News.
Naltrexone, bupropion combination helps individuals lose excess weight
August 17th 2010Investigational combination treatment with sustained-release (SR) naltrexone and bupropion (Contrave, Orexigen Therapeutics) combined with lifestyle modification, appears effective in helping people lose 5% or more of their excess body weight, according to research published online July 30 in The Lancet and reported by HealthDay News.
Generic substitution: An opportunity to educate consumers
August 15th 2010In a recent survey by Medco Health Solutions Inc., only 66% of 1,092 patients with insurance surveyed "agreed that a generic drug is the same as the brand-name medication - many patients are still not comfortable using a generic and others still consider brand-name drugs to be superior."
Keeping pharmacy staff: Best practices
August 15th 2010With many pharmacists approaching retirement, positions are opening up. For professionals tasked with greater responsibility and longer working hours, greener pastures have an undeniable appeal. In this business climate, how can employers hold onto their pharmacy professionals?